Healthcare -
Biotechnology - NASDAQ - US
$ 18.27
-3.43 %
$ 895 M
Market Cap
-10.42
P/E
ELVN - REVENUE
Revenue ELVN - Enliven Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR